Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms, Germ Cell and Embryonal | 5 | 2023 | 490 | 1.570 |
Why?
|
Mesenchymal Stem Cells | 23 | 2011 | 1631 | 1.420 |
Why?
|
Myocardial Reperfusion Injury | 15 | 2011 | 478 | 1.220 |
Why?
|
Splenectomy | 3 | 2018 | 391 | 1.170 |
Why?
|
Mesenchymal Stem Cell Transplantation | 14 | 2011 | 497 | 1.120 |
Why?
|
Wilms Tumor | 3 | 2023 | 375 | 0.990 |
Why?
|
Catheterization, Central Venous | 3 | 2021 | 527 | 0.860 |
Why?
|
Endotoxemia | 4 | 2011 | 196 | 0.820 |
Why?
|
Hepatocyte Growth Factor | 7 | 2015 | 267 | 0.780 |
Why?
|
Renal Insufficiency | 3 | 2023 | 809 | 0.670 |
Why?
|
Transforming Growth Factor alpha | 8 | 2011 | 135 | 0.660 |
Why?
|
Gallbladder Diseases | 1 | 2020 | 138 | 0.650 |
Why?
|
Intestinal Obstruction | 1 | 2023 | 431 | 0.640 |
Why?
|
Cholecystectomy | 2 | 2020 | 406 | 0.620 |
Why?
|
Splenic Diseases | 1 | 2018 | 90 | 0.590 |
Why?
|
Sepsis | 5 | 2018 | 2579 | 0.550 |
Why?
|
Appendix | 1 | 2017 | 110 | 0.520 |
Why?
|
Myocardium | 15 | 2011 | 4690 | 0.500 |
Why?
|
Hepatoblastoma | 1 | 2015 | 88 | 0.480 |
Why?
|
Neoplasms | 10 | 2023 | 21986 | 0.460 |
Why?
|
Vascular Endothelial Growth Factor A | 16 | 2011 | 3480 | 0.460 |
Why?
|
Ovarian Neoplasms | 4 | 2023 | 4872 | 0.450 |
Why?
|
Neuroblastoma | 4 | 2024 | 1247 | 0.450 |
Why?
|
Child | 42 | 2024 | 79782 | 0.430 |
Why?
|
Paracrine Communication | 5 | 2011 | 276 | 0.430 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2017 | 326 | 0.420 |
Why?
|
Myocardial Ischemia | 11 | 2011 | 2109 | 0.420 |
Why?
|
Spleen | 2 | 2018 | 2295 | 0.410 |
Why?
|
Hernia, Inguinal | 3 | 2021 | 220 | 0.400 |
Why?
|
Kidney Neoplasms | 3 | 2023 | 4220 | 0.380 |
Why?
|
Gastroschisis | 1 | 2012 | 99 | 0.370 |
Why?
|
STAT3 Transcription Factor | 6 | 2011 | 869 | 0.340 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2010 | 106 | 0.340 |
Why?
|
Child, Preschool | 21 | 2024 | 42045 | 0.330 |
Why?
|
Teratoma | 2 | 2023 | 402 | 0.330 |
Why?
|
Infant | 21 | 2024 | 36045 | 0.330 |
Why?
|
Cardiac Tamponade | 1 | 2010 | 175 | 0.320 |
Why?
|
Peritoneal Dialysis | 1 | 2010 | 157 | 0.320 |
Why?
|
Duodenal Obstruction | 1 | 2008 | 23 | 0.320 |
Why?
|
Osteosarcoma | 2 | 2024 | 896 | 0.310 |
Why?
|
Rats, Sprague-Dawley | 21 | 2011 | 8143 | 0.310 |
Why?
|
Pericardial Effusion | 1 | 2010 | 247 | 0.310 |
Why?
|
Duodenal Diseases | 1 | 2008 | 99 | 0.300 |
Why?
|
Bone Neoplasms | 3 | 2024 | 2524 | 0.290 |
Why?
|
Culture Media | 1 | 2009 | 899 | 0.280 |
Why?
|
Adolescent | 29 | 2024 | 87819 | 0.280 |
Why?
|
Interleukin-1beta | 6 | 2011 | 995 | 0.280 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2212 | 0.270 |
Why?
|
Immunomodulation | 1 | 2010 | 544 | 0.270 |
Why?
|
Heart | 6 | 2010 | 4382 | 0.260 |
Why?
|
Interleukin-6 | 8 | 2011 | 3206 | 0.260 |
Why?
|
Neoplasms, Second Primary | 3 | 2024 | 1051 | 0.250 |
Why?
|
Cell Proliferation | 5 | 2010 | 10405 | 0.240 |
Why?
|
Catheters, Indwelling | 2 | 2021 | 427 | 0.240 |
Why?
|
Rats | 24 | 2011 | 23676 | 0.230 |
Why?
|
Infant, Newborn | 11 | 2023 | 26176 | 0.230 |
Why?
|
Tumor Necrosis Factor-alpha | 11 | 2011 | 4338 | 0.230 |
Why?
|
Hematoma | 1 | 2008 | 768 | 0.220 |
Why?
|
Male | 62 | 2024 | 358180 | 0.220 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 5 | 2010 | 256 | 0.220 |
Why?
|
Incidence | 10 | 2024 | 21217 | 0.220 |
Why?
|
Retrospective Studies | 23 | 2024 | 79984 | 0.210 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 1245 | 0.210 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2015 | 2294 | 0.210 |
Why?
|
Humans | 73 | 2024 | 757566 | 0.200 |
Why?
|
Interleukin-10 | 4 | 2011 | 1173 | 0.200 |
Why?
|
Survivors | 5 | 2023 | 2370 | 0.200 |
Why?
|
Cell Survival | 4 | 2010 | 5781 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1651 | 0.200 |
Why?
|
Hernia, Femoral | 1 | 2021 | 18 | 0.190 |
Why?
|
Indenes | 1 | 2021 | 58 | 0.190 |
Why?
|
Female | 49 | 2024 | 389943 | 0.180 |
Why?
|
Polycythemia | 1 | 2021 | 125 | 0.180 |
Why?
|
Postoperative Complications | 3 | 2021 | 15532 | 0.180 |
Why?
|
Appendectomy | 2 | 2020 | 430 | 0.170 |
Why?
|
Paraganglioma | 1 | 2021 | 142 | 0.170 |
Why?
|
Estrogen Receptor beta | 3 | 2009 | 168 | 0.170 |
Why?
|
Hernia, Umbilical | 1 | 2021 | 102 | 0.170 |
Why?
|
Stem Cells | 2 | 2009 | 3521 | 0.170 |
Why?
|
Tacrolimus | 1 | 2023 | 733 | 0.170 |
Why?
|
Liver Neoplasms | 1 | 2015 | 4314 | 0.170 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2010 | 584 | 0.160 |
Why?
|
Estrogens | 4 | 2010 | 1519 | 0.160 |
Why?
|
Receptor Cross-Talk | 2 | 2009 | 116 | 0.160 |
Why?
|
Risk Factors | 10 | 2024 | 73708 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2011 | 2859 | 0.160 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 6 | 2011 | 684 | 0.160 |
Why?
|
Intestinal Mucosa | 1 | 2009 | 3021 | 0.150 |
Why?
|
Stem Cell Transplantation | 4 | 2010 | 1598 | 0.150 |
Why?
|
Hemorrhage | 1 | 2010 | 3399 | 0.150 |
Why?
|
Rectal Diseases | 1 | 2019 | 143 | 0.150 |
Why?
|
Testicular Diseases | 1 | 2018 | 73 | 0.150 |
Why?
|
Cyclosporine | 1 | 2000 | 777 | 0.150 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1923 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 345 | 0.140 |
Why?
|
Hernia, Ventral | 1 | 2021 | 215 | 0.140 |
Why?
|
Glucose | 1 | 2009 | 4336 | 0.140 |
Why?
|
Cell Hypoxia | 2 | 2009 | 656 | 0.140 |
Why?
|
Signal Transduction | 10 | 2021 | 23335 | 0.140 |
Why?
|
North America | 1 | 2020 | 1273 | 0.140 |
Why?
|
Thymectomy | 1 | 2017 | 194 | 0.130 |
Why?
|
Animals | 39 | 2011 | 167718 | 0.130 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2021 | 732 | 0.130 |
Why?
|
Intubation, Gastrointestinal | 1 | 2017 | 166 | 0.130 |
Why?
|
Neoplasm Staging | 4 | 2023 | 11082 | 0.130 |
Why?
|
Graft Survival | 2 | 2010 | 3794 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1135 | 0.130 |
Why?
|
Infant, Newborn, Diseases | 1 | 2021 | 591 | 0.130 |
Why?
|
Lipopolysaccharides | 4 | 2011 | 2203 | 0.120 |
Why?
|
Estrogen Receptor alpha | 2 | 2009 | 580 | 0.120 |
Why?
|
Glomerulonephritis, Membranoproliferative | 1 | 1995 | 40 | 0.120 |
Why?
|
Survival Rate | 5 | 2024 | 12684 | 0.120 |
Why?
|
Cells, Cultured | 8 | 2011 | 18936 | 0.120 |
Why?
|
Hepatitis Antibodies | 1 | 1995 | 68 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 6 | 2011 | 3799 | 0.120 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1269 | 0.120 |
Why?
|
Chronic Disease | 4 | 2023 | 9263 | 0.120 |
Why?
|
Surgical Procedures, Operative | 2 | 2019 | 1903 | 0.120 |
Why?
|
Hospital Charges | 1 | 2016 | 351 | 0.120 |
Why?
|
Myasthenia Gravis | 1 | 2017 | 212 | 0.120 |
Why?
|
Graft vs Host Reaction | 1 | 1994 | 103 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2011 | 193 | 0.110 |
Why?
|
Enteral Nutrition | 2 | 2017 | 786 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2022 | 1152 | 0.110 |
Why?
|
Laparoscopy | 3 | 2020 | 2032 | 0.110 |
Why?
|
Lymphocyte Transfusion | 1 | 1994 | 232 | 0.100 |
Why?
|
Biological Products | 1 | 2022 | 903 | 0.100 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 441 | 0.100 |
Why?
|
Poverty | 1 | 2024 | 2685 | 0.100 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 3709 | 0.100 |
Why?
|
Mimosine | 1 | 2011 | 7 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1546 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5648 | 0.100 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2011 | 23 | 0.100 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 614 | 0.100 |
Why?
|
Ventricular Function, Left | 5 | 2011 | 3858 | 0.100 |
Why?
|
Young Adult | 10 | 2024 | 58755 | 0.100 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 2 | 2009 | 173 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2009 | 411 | 0.100 |
Why?
|
Device Removal | 1 | 2016 | 629 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1666 | 0.090 |
Why?
|
Transplantation Chimera | 1 | 1994 | 594 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2010 | 1879 | 0.090 |
Why?
|
Cardiotonic Agents | 2 | 2011 | 539 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1784 | 0.090 |
Why?
|
Colitis, Ulcerative | 1 | 2023 | 1919 | 0.090 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13268 | 0.090 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39020 | 0.090 |
Why?
|
Cyclopentanes | 1 | 2010 | 86 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1715 | 0.090 |
Why?
|
Indiana | 1 | 2010 | 92 | 0.090 |
Why?
|
Cholelithiasis | 1 | 1992 | 407 | 0.090 |
Why?
|
Pericardiocentesis | 1 | 2010 | 78 | 0.090 |
Why?
|
Ischemic Preconditioning | 1 | 2010 | 89 | 0.090 |
Why?
|
Gastrostomy | 1 | 2012 | 322 | 0.080 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 816 | 0.080 |
Why?
|
Adult Stem Cells | 1 | 2011 | 221 | 0.080 |
Why?
|
LLC-PK1 Cells | 1 | 2009 | 125 | 0.080 |
Why?
|
Testosterone | 3 | 2010 | 2465 | 0.080 |
Why?
|
HMGB1 Protein | 1 | 2010 | 137 | 0.080 |
Why?
|
Lung Diseases | 1 | 2019 | 1908 | 0.080 |
Why?
|
Vasoconstriction | 2 | 2008 | 592 | 0.080 |
Why?
|
Thymus Gland | 1 | 1994 | 1240 | 0.080 |
Why?
|
Sex Characteristics | 5 | 2010 | 2621 | 0.080 |
Why?
|
Mice, Inbred C57BL | 13 | 2011 | 21990 | 0.080 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2010 | 227 | 0.080 |
Why?
|
Adult | 16 | 2024 | 219725 | 0.080 |
Why?
|
STAT Transcription Factors | 1 | 2009 | 188 | 0.080 |
Why?
|
Arthritis | 1 | 1994 | 666 | 0.080 |
Why?
|
Caspase 3 | 4 | 2011 | 728 | 0.080 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 522 | 0.070 |
Why?
|
Janus Kinases | 1 | 2009 | 249 | 0.070 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 344 | 0.070 |
Why?
|
Self Report | 1 | 2019 | 3709 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4159 | 0.070 |
Why?
|
Nitriles | 2 | 2009 | 950 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3887 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3667 | 0.070 |
Why?
|
Estradiol | 3 | 2010 | 1933 | 0.070 |
Why?
|
Steroids | 2 | 2011 | 926 | 0.070 |
Why?
|
Transplantation Immunology | 1 | 2009 | 532 | 0.070 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2011 | 242 | 0.070 |
Why?
|
Platelet Transfusion | 1 | 2010 | 294 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 13597 | 0.070 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 589 | 0.070 |
Why?
|
Reperfusion Injury | 2 | 2010 | 1023 | 0.070 |
Why?
|
Toll-Like Receptor 4 | 1 | 2010 | 576 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2009 | 590 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 640 | 0.070 |
Why?
|
Caspases | 1 | 2009 | 876 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2010 | 701 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 1994 | 2691 | 0.060 |
Why?
|
Ultrasonography | 2 | 2017 | 5951 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 611 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2000 | 4214 | 0.060 |
Why?
|
Quinolines | 1 | 2010 | 758 | 0.060 |
Why?
|
Inflammation | 5 | 2011 | 10709 | 0.060 |
Why?
|
Mice, Knockout | 8 | 2011 | 14345 | 0.060 |
Why?
|
Cryopreservation | 2 | 2021 | 717 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3762 | 0.060 |
Why?
|
Disease Models, Animal | 7 | 2011 | 18114 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3793 | 0.060 |
Why?
|
Ventricular Function, Right | 1 | 2008 | 609 | 0.060 |
Why?
|
Time Factors | 4 | 2020 | 39811 | 0.060 |
Why?
|
Databases, Factual | 1 | 2019 | 7927 | 0.060 |
Why?
|
Sacrococcygeal Region | 1 | 2023 | 53 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1956 | 0.060 |
Why?
|
Mice | 17 | 2011 | 81066 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4456 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2010 | 2443 | 0.060 |
Why?
|
Treatment Outcome | 7 | 2023 | 64242 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11709 | 0.050 |
Why?
|
Antioxidants | 1 | 2011 | 1665 | 0.050 |
Why?
|
Myocarditis | 1 | 2010 | 765 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1262 | 0.050 |
Why?
|
Prognosis | 6 | 2023 | 29488 | 0.050 |
Why?
|
Perfusion | 3 | 2011 | 1374 | 0.050 |
Why?
|
Normetanephrine | 1 | 2021 | 25 | 0.050 |
Why?
|
Ovariectomy | 2 | 2019 | 610 | 0.050 |
Why?
|
Fetus | 1 | 2009 | 1860 | 0.050 |
Why?
|
United States | 8 | 2024 | 71902 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2011 | 1795 | 0.050 |
Why?
|
Graft Rejection | 2 | 2010 | 4427 | 0.050 |
Why?
|
Chromogranins | 1 | 2021 | 160 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2023 | 6807 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2011 | 5861 | 0.050 |
Why?
|
Lung | 1 | 2019 | 9973 | 0.040 |
Why?
|
Recovery of Function | 4 | 2011 | 2969 | 0.040 |
Why?
|
Groin | 1 | 2021 | 106 | 0.040 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2020 | 33 | 0.040 |
Why?
|
Heart Arrest | 1 | 2010 | 1494 | 0.040 |
Why?
|
Pulmonary Artery | 1 | 2008 | 1916 | 0.040 |
Why?
|
Aged | 7 | 2023 | 167890 | 0.040 |
Why?
|
Swine | 1 | 2009 | 5891 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2021 | 166 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2021 | 551 | 0.040 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1945 | 0.040 |
Why?
|
Echocardiography | 1 | 2011 | 4963 | 0.040 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11422 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5031 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2023 | 508 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4235 | 0.040 |
Why?
|
Colectomy | 1 | 2023 | 687 | 0.040 |
Why?
|
Cytokines | 2 | 2010 | 7336 | 0.040 |
Why?
|
Vincristine | 1 | 2020 | 1036 | 0.040 |
Why?
|
Apoptosis | 2 | 2011 | 9466 | 0.040 |
Why?
|
Risk Assessment | 3 | 2018 | 23816 | 0.040 |
Why?
|
Crohn Disease | 1 | 2010 | 2275 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 219192 | 0.040 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1565 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2011 | 2674 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1748 | 0.040 |
Why?
|
Prevalence | 3 | 2021 | 15640 | 0.040 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 1996 | 516 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3526 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4427 | 0.040 |
Why?
|
Age Factors | 2 | 2011 | 18326 | 0.030 |
Why?
|
Fundoplication | 1 | 2017 | 144 | 0.030 |
Why?
|
Neural Crest | 1 | 2018 | 279 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 561 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2023 | 1744 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2378 | 0.030 |
Why?
|
Phenols | 2 | 2009 | 514 | 0.030 |
Why?
|
Macrophages | 1 | 2010 | 5732 | 0.030 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 3603 | 0.030 |
Why?
|
Syndrome | 1 | 2021 | 3261 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2023 | 3591 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2017 | 249 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 824 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54092 | 0.030 |
Why?
|
Hepatitis C Antibodies | 1 | 1995 | 145 | 0.030 |
Why?
|
Coronary Disease | 1 | 2009 | 5915 | 0.030 |
Why?
|
Togo | 1 | 1994 | 8 | 0.030 |
Why?
|
Ovary | 1 | 2019 | 958 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 1996 | 5489 | 0.030 |
Why?
|
Spondylitis | 1 | 1994 | 20 | 0.030 |
Why?
|
Transplantation Conditioning | 1 | 2021 | 1588 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2009 | 1245 | 0.030 |
Why?
|
Lower Extremity | 1 | 2022 | 1188 | 0.030 |
Why?
|
Cohort Studies | 3 | 2023 | 41190 | 0.030 |
Why?
|
Arthritis, Gouty | 1 | 1994 | 28 | 0.030 |
Why?
|
Oocytes | 1 | 2019 | 1165 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 587 | 0.030 |
Why?
|
Myocardial Contraction | 2 | 2009 | 1516 | 0.030 |
Why?
|
Kidney | 2 | 2019 | 7012 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2010 | 4673 | 0.030 |
Why?
|
France | 1 | 1995 | 497 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 1477 | 0.030 |
Why?
|
Nephrectomy | 1 | 2018 | 934 | 0.030 |
Why?
|
Scoliosis | 1 | 2019 | 734 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1627 | 0.030 |
Why?
|
Recurrence | 2 | 2018 | 8426 | 0.030 |
Why?
|
Nephrosis, Lipoid | 1 | 1993 | 45 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 1994 | 751 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2011 | 1926 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2009 | 10749 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2010 | 5105 | 0.020 |
Why?
|
Ursodeoxycholic Acid | 1 | 1992 | 79 | 0.020 |
Why?
|
Smad3 Protein | 1 | 2011 | 166 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2011 | 222 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 1994 | 1758 | 0.020 |
Why?
|
Models, Biological | 4 | 2010 | 9459 | 0.020 |
Why?
|
Lithotripsy | 1 | 1992 | 140 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2010 | 92 | 0.020 |
Why?
|
Acute Disease | 2 | 2011 | 7225 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2009 | 3432 | 0.020 |
Why?
|
Spinal Fusion | 1 | 2019 | 1278 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1994 | 1351 | 0.020 |
Why?
|
Operating Rooms | 1 | 2016 | 789 | 0.020 |
Why?
|
Graft Enhancement, Immunologic | 1 | 2009 | 57 | 0.020 |
Why?
|
Proteinuria | 1 | 1993 | 594 | 0.020 |
Why?
|
Preoperative Care | 1 | 2019 | 2246 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2011 | 282 | 0.020 |
Why?
|
HMGB Proteins | 1 | 2009 | 45 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2024 | 12397 | 0.020 |
Why?
|
Species Specificity | 1 | 1994 | 2413 | 0.020 |
Why?
|
Castration | 1 | 2009 | 151 | 0.020 |
Why?
|
Biopsy | 2 | 2019 | 6757 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
Gliadin | 1 | 1989 | 80 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 1992 | 351 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13263 | 0.020 |
Why?
|
Flutamide | 1 | 2009 | 95 | 0.020 |
Why?
|
Estrus | 1 | 2008 | 70 | 0.020 |
Why?
|
Pyrazoles | 2 | 2009 | 1992 | 0.020 |
Why?
|
Glomerulonephritis, IGA | 1 | 1989 | 62 | 0.020 |
Why?
|
Platelet Count | 1 | 2011 | 774 | 0.020 |
Why?
|
Propionates | 1 | 2009 | 182 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2017 | 817 | 0.020 |
Why?
|
Caspase 8 | 1 | 2009 | 189 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2008 | 124 | 0.020 |
Why?
|
Peritonitis | 1 | 2010 | 369 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2009 | 204 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2010 | 385 | 0.020 |
Why?
|
Phenylephrine | 1 | 2008 | 293 | 0.020 |
Why?
|
Injections | 1 | 2011 | 829 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2009 | 256 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 4808 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1994 | 1557 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10075 | 0.020 |
Why?
|
Safety | 1 | 2012 | 1147 | 0.020 |
Why?
|
Hepacivirus | 1 | 1995 | 1333 | 0.020 |
Why?
|
Drug Synergism | 1 | 2011 | 1746 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3524 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 1989 | 336 | 0.020 |
Why?
|
Plant Proteins | 1 | 1989 | 368 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1994 | 1765 | 0.020 |
Why?
|
Interleukin-1 | 1 | 2010 | 1249 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2016 | 1181 | 0.020 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 970 | 0.020 |
Why?
|
Diastole | 1 | 2008 | 781 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 2388 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6384 | 0.020 |
Why?
|
Orchiectomy | 1 | 2008 | 463 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1694 | 0.020 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 606 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2390 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2010 | 725 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 1989 | 979 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3241 | 0.020 |
Why?
|
Sex Factors | 2 | 2010 | 10495 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 651 | 0.020 |
Why?
|
Heart Failure | 1 | 2009 | 11595 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2008 | 20499 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2010 | 3593 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1554 | 0.010 |
Why?
|
Carbon Dioxide | 1 | 2008 | 1143 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1996 | 4350 | 0.010 |
Why?
|
Extremities | 1 | 2009 | 865 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9245 | 0.010 |
Why?
|
Protein Kinases | 1 | 2010 | 1608 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5483 | 0.010 |
Why?
|
Coronary Circulation | 1 | 2009 | 1561 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1752 | 0.010 |
Why?
|
Osteogenesis | 1 | 2010 | 1271 | 0.010 |
Why?
|
Adipocytes | 1 | 2010 | 1178 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 1996 | 4550 | 0.010 |
Why?
|
Models, Animal | 1 | 2009 | 2110 | 0.010 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1256 | 0.010 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2008 | 615 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2010 | 11469 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1403 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2472 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 2901 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29712 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5777 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7798 | 0.010 |
Why?
|
Regeneration | 1 | 2010 | 1505 | 0.010 |
Why?
|
Antibodies | 1 | 1989 | 2420 | 0.010 |
Why?
|
Radiography | 1 | 1992 | 6956 | 0.010 |
Why?
|
Ischemia | 1 | 2009 | 1863 | 0.010 |
Why?
|
Androgen Antagonists | 1 | 2009 | 1400 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4110 | 0.010 |
Why?
|
Coronary Vessels | 1 | 2011 | 3072 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25924 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8512 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15781 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15207 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 3043 | 0.010 |
Why?
|
Rats, Inbred WF | 1 | 1996 | 138 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2008 | 3806 | 0.010 |
Why?
|
Stroke Volume | 1 | 2008 | 5461 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36270 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7982 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2010 | 7840 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11890 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1996 | 1870 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6204 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1992 | 58558 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1993 | 2357 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1993 | 14637 | 0.000 |
Why?
|